luye pharma (02186): The antidepressant class 1 innovative drug (LY03021) has been approved to conduct clinical trials.

Luye Pharma (02186) announced that the group's first category of innovative drug LY03021 has obtained approval from China's National Medical Products Administration...

Zhitong FinanceNov 10 23:11 ET

UNAUDITED SEMI-ANNUAL REPORT FOR THE PERIOD ENDED 30 JUNE 2024

HKEXAug 27 23:31 ET · Announcements

AUDITED ACCOUNTS AS AT 31 DECEMBER 2023

HKEXApr 29 03:38 ET · Announcements

Fubon FTSE Taiwan RIC Capped Index ETF: UNAUDITED SEMI-ANNUAL REPORT FOR THE PERIOD ENDED 30 JUNE 2023

HKEXAug 24, 2023 05:00 ET · Announcements

Fubon FTSE Taiwan RIC Capped Index ETF: AUDITED ACCOUNTS AS AT 31 DECEMBER 2022

HKEXApr 28, 2023 01:16 ET · Announcements

Fubon FTSE Taiwan RIC Capped Index ETF: Semi-Annual Report 2022

HKEXAug 29, 2022 06:09 ET · Announcements